Annual report pursuant to Section 13 and 15(d)

Inventories, net (Tables)

v3.22.2.2
Inventories, net (Tables)
12 Months Ended
May 31, 2022
Inventory Disclosure [Abstract]  
Summary of Inventories, net of reserves

As of May 31,

(in thousands)

    

2022

    

2021

Raw materials

$

16,264

$

28,085

Work-in-progress

 

1,665

 

65,394

Total inventories, net

$

17,929

$

93,479

Schedule of remaining shelf life of inventory

Raw Materials

Work-in-progress

(in thousands, Expiration period ending May 31, )

    

Remaining shelf-life (mos)

    

Specialized

Resins

Other

Total Raw Materials

Bulk drug product

Finished drug product

Total inventories

2023

0 to 12

$

3,658

-

1,421

$

5,079

$

1,824

$

-

$

6,903

2024

13 to 24

682

16,264

1,590

18,536

1,665

-

20,201

2025

25 to 36

2,099

-

-

2,099

-

29,142

31,241

2026

37 to 48

731

-

-

731

-

32,344

33,075

Thereafter

49 or more

-

-

-

-

-

-

-

Inventories, gross

7,170

16,264

3,011

26,445

3,489

61,486

91,420

Write-off

(7,170)

-

(3,011)

(10,181)

(1,824)

(61,486)

(73,491)

Inventories, net

$

-

16,264

-

$

16,264

$

1,665

$

-

$

17,929